Medium intensity oral anticoagulants versus aspirin after cerebral ischaemia of arterial origin (ESPRIT): a randomised controlled trial
- 5 January 2007
- journal article
- research article
- Published by Elsevier in The Lancet Neurology
- Vol. 6 (2), 115-124
- https://doi.org/10.1016/s1474-4422(06)70685-8
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trialThe Lancet, 2006
- Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patientsBMJ, 2002
- Efficacy of oral anticoagulants compared with aspirin after infrainguinal bypass surgery (The Dutch Bypass Oral anticoagulants or Aspirin study): a randomised trialThe Lancet, 2000
- Oral anticoagulant therapy in patients with coronary artery disease: a meta-analysis.JAMA, 1999
- Cumulative meta-analysis of aspirin efficacy after cerebral ischaemia of arterial originJournal of Neurology, Neurosurgery & Psychiatry, 1999
- A randomized trial of anticoagulants versus aspirin after cerebral ischemia of presumed arterial originAnnals of Neurology, 1997
- Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trialThe Lancet, 1996
- Aspirin at any dose above 30 mg offers only modest protection after cerebral ischaemia.Journal of Neurology, Neurosurgery & Psychiatry, 1996
- Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor strokeThe Lancet, 1993
- Secondary prevention of strokeThe Lancet, 1992